CIK: 0001019231 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 13, 2018
Total Value ($000): $80,904 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRUST | 204,346 | $59,407 | 73.4% | $263.15 | — | ETFS | 78462F103 |
| TXN | TEXAS INSTRUMENTS INC | 32,800 | $3,519 | 4.3% | $57.24 | +57.7% | COM | 882508104 |
| VEA | VANGUARD FTSE DEV MKTS | 76,874 | $3,326 | 4.1% | $38.86 | — | ETFS | 921943858 |
| — | AEGLEA BIOTHERAPEUTICS INC | 335,279 | $3,209 | 4.0% | $6.41 | — | COM | 00773J103 |
| VOO | VANGUARD 500 INDEX FUND | 11,141 | $2,975 | 3.7% | $185.47 | — | ETFS | 922908363 |
| VOE | VANGUARD MID-CAP VALUE ETF | 25,701 | $2,906 | 3.6% | $87.03 | — | ETFS | 922908512 |
| VWO | VANGUARD MSCI EMERGING MKTS | 61,083 | $2,504 | 3.1% | $38.79 | — | ETFS | 922042858 |
| VDE | VANGUARD ENERGY ETF | 10,193 | $1,071 | 1.3% | $111.00 | — | ETFS | 92204A306 |
| VNQ | VANGUARD REIT ETF | 10,648 | $859 | 1.1% | $73.67 | — | ETFS | 922908553 |
| LXRX | LEXICON PHARMACEUTICALS INC | 35,714 | $381 | 0.5% | $7.34 | +56.0% | COM | 528872302 |
| — | PLX PHARMA INC | 62,673 | $254 | 0.3% | $6.14 | — | COM | 72942A107 |
| — | BIO-PATH HOLDINGS INC | 383,089 | $226 | 0.3% | $2.00 | — | COM | 09057N201 |
| — | APOLLO ENDOSURGERY INC | 15,601 | $112 | 0.1% | $12.52 | — | COM | 03767D108 |
| XOM | EXXON MOBIL CORPORATION | 583 | $50 | 0.1% | $58.19 | 0.0% | COM | 30231G102 |
| UTHR | UNITED THERAPEUTICS CORP | 315 | $40 | 0.0% | $123.69 | 0.0% | COM | 91307C102 |
| ABT | ABBOTT LABORATORIES | 343 | $25 | 0.0% | $57.83 | 0.0% | COM | 002824100 |
| ABBV | ABBVIE INC. | 263 | $25 | 0.0% | $69.17 | 0.0% | COM | 00287Y109 |
| RF | REGIONS FINANCIAL CORP | 270 | $5 | 0.0% | $13.95 | 0.0% | COM | 7591EP100 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $5 | 0.0% | $20.00 | +70.4% | COM | 736508847 |
| HBAN | HUNTINGTON BANCSHARES INC | 335 | $5 | 0.0% | $11.11 | 0.0% | COM | 446150104 |